High estrogen exposure may not be detrimental on endometrial receptivity in women with PCOS

References

• Paulson RJ, Sauer MV, Lobo RA. Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril 1990;53:870–4.
   PubMed Web of Science ®Google Scholar
• Garcia JE, Acosta AA, Hsiu JG, Jones HW. Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin/human chorionic gonadotropin for in vitro fertilization. Fertil Steril 1984;41:31–7.
   PubMed Web of Science ®Google Scholar
• Bladford AJ, Najmabadi S, Paulson RJ. Ultrastructural characteristics of the luteal phase endometrium in donors undergoing controlled ovarian hyperstimulation. Fertil Steril 1997;67:625–30.
   PubMed Web of Science ®Google Scholar
• Simón C, Mercader A, Frances A, et al. Hormonal regulation of serum and endometrial IL-1α, IL-1β, and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supraphysiological steroid level conditions. J Reprod Immunol 1996;31:165–84.
   PubMed Web of Science ®Google Scholar
• Pellicer A, Ruiz A, Castellvi RM, et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?. Hum Reprod 1989;4:536–40.
   PubMed Web of Science ®Google Scholar
• Tarín JJ, Pellicer A. Consequences of high ovarian response to gonadotrophins: a cytogenetic analysis of unfertilized human oocytes. Fertil Steril 1990;54:665–70.
   PubMed Web of Science ®Google Scholar
• Simon C, Cano F, Valbuena D, et al. Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol levels in high and normal responder patients. Hum Reprod 1995;10:2432–7.
   PubMed Web of Science ®Google Scholar
• Pellicer A, Valbuena D, Cano F, et al. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril 1996;65:1190–5.
   PubMed Web of Science ®Google Scholar
• Testart J, Belaisch-Allart J, Forman R, et al. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability. Hum Reprod 1989;4:192–7.
   PubMed Web of Science ®Google Scholar
• Toner J, Brzyski R, Oehninger S, et al. Combined impact of the number of preovulatory oocytes and cryo-preservation on IVF outcome. Hum Reprod 1991;6:284–9.
   PubMed Web of Science ®Google Scholar
• Chenette PE, Sauer MV, Paulson RJ. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril 1990;54:858–63.
   PubMed Web of Science ®Google Scholar
• Ozkaya E, Kutlu T, Abide Yayla C, et al. Area under the curve of temporal estrogen and progesterone measurements during assisted reproductive technology: Which hormone is the main determinant of cycle outcome? J Obstet Gynaecol Res 2018;44:263–9.
   PubMed Web of Science ®Google Scholar
• Kutlu T, Ozkaya E, Ayvaci H, et al. Area under curve of temporal estradiol measurements for prediction of the detrimental effect of estrogen exposure on implantation. Int J Gynaecol Obstet 2016; 135:168–71.
   PubMed Web of Science ®Google Scholar
• Simón C, Garcia Velasco JJ, Valbuena D, et al. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril 1998;70:234–9.
   PubMed Web of Science ®Google Scholar
• Yumuşak OH, Kahyaoglu S, Özgü Erdinç AS, et al. Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure? Turk J Obstet Gynecol 2014;11:159–64.
   Google Scholar
• Eshre TR. Group ASPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
   Web of Science ®Google Scholar
• Rabinovici J, Kushnir O, Shalev J, et al. Rescue of menotrophin cycles prone to develop ovarian hyperstimulation. Br J Obstet Gynaecol 1987;94:1098–102.
   PubMedGoogle Scholar
• Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003;28:916–31.
   PubMed Web of Science ®Google Scholar
• Oktem O, Akin N, Bildik G, et al. FSH Stimulation promotes progesterone synthesis and output from human granulosa cells without luteinization. Hum Reprod 2017;32:643–52.
   PubMed Web of Science ®Google Scholar
• Griesinger G, Mannaerts B, Andersen CY, et al. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials . Fertil Steril 2013;100:1622–8. e1621–1623.
   PubMed Web of Science ®Google Scholar
• Kyrou D, Al-Azemi M, Papanikolaou EG, et al. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol 2012;162:165–8.
   PubMed Web of Science ®Google Scholar
• Fatemi HM, Van Vaerenbergh I. Significance of premature progesterone rise in IVF. Curr Opin Obstet Gynecol 2015;27:242–8.
   PubMed Web of Science ®Google Scholar
• Al Azemi M, Kyrou D, Kolibianakis EM, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012; 24:381–8.
   PubMed Web of Science ®Google Scholar
• Rezaee Z, Ghaseminejad A, Forootan M, et al. Assessment of Serum Progesterone Level on the Day of hCG Injection in Infertile Polycystic Ovarian Syndrome Patients Referred to Women's Hospital, Tehran, 2009. Int J Fertil Steril 2012;5:231–4.
   PubMed Web of Science ®Google Scholar
• Doldi N, Marsiglio E, Destefani A, et al. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 1999; 14:601–5.
   PubMed Web of Science ®Google Scholar
• Requena A, Cruz M, Bosch E, et al. High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. Reprod Biol Endocrinol 2014;12:69.
   PubMed Web of Science ®Google Scholar
• Nardo LG, Cheema P, Gelbaya TA, et al. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization. Hum Fertil (Camb) 2006;9:175–80.
   PubMedGoogle Scholar
• Moon HS, Joo BS, Moon SE, et al. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome. Fertil Steril 2008;90:2172–8.
   PubMed Web of Science ®Google Scholar
• Isaza V, García-Velasco JA, Aragonés M, et al. Oocyte and embryo quality after coasting: the experience from oocyte donation. Hum Reprod 2002;17:1777–82.
   PubMed Web of Science ®Google Scholar